British American Tobacco Industries p.l.c. Common Stock ADR (BTI)
BTI trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1303523/000130352326000017/0001303523-26-000017-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-12-31. Converted from GBP at 0.7538 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | BTI on NYSE |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United Kingdom |
| IPO year | 1998 |
| SEC CIK | 0001303523 |
| SEC industry code | Cigarettes |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $34.0B |
| Net income | $10.3B |
| Operating income | Not in SEC XBRL data |
| Net margin | 30.3% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | 11.7× |
| P/S (computed) | 3.5× |
Reported in GBP; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2026-08-04 |
| Latest annual report | 20-F | 2026-02-13 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-09 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +5.0% |
| 1 month | +0.1% |
| 3 months | -10.4% |
| Year to date | -0.0% |
| 1 year | +11.4% |
| From 52-week high | -15.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MO | Altria Group Inc. | $71.56 | -0.14% | $119.5B |
| PM | Philip Morris International Inc | $199.29 | -1.34% | $310.6B |
| DFTX | Definium Therapeutics Inc. Common Shares | $34.38 | -2.33% | $4.6B |
| RGC | Regencell Bioscience Holdings Limited | $8.19 | +14.87% | $4.1B |
| RLX | RLX Technology Inc. | $1.71 | -0.58% | $2.1B |
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $10.11 | -2.69% | $1.9B |
| CRON | Cronos Group Inc. Common Share | $3.20 | -0.31% | $1.2B |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier